1 year return (CAGR)
319.22%
Sutro Biopharma Exchange (NASDAQ, USD)
STRO
16.56
+2.14 (+5.68%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-4.69%
5 year return (CAGR)
-27.95%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
659.90M
Price/Sales
6.44
Ent value
908.05M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 37.32 |
| Daily high | 40.25 |
| Daily low | 36.48 |
| Daily Volume | 258K |
| All-time high | 275.40 |
| 1y analyst estimate | 47.23 |
| Beta | 1.51 |
| EPS (TTM) | -10.90 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 12 Mar 2026 |
Downside potential
Loading...
Downside potential data
| STRO | S&P500 | |
| Current price drop from All-time high | -93.99% | -2.63% |
| Highest price drop | -98.10% | -56.47% |
| Date of highest drop | 17 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -60.70% | -10.68% |
| Avg time to new high | 137 days | 12 days |
| Max time to new high | 1329 days | 1805 days |
News
